These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32746545)

  • 1. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
    Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
    Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
    Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DICER1 hot-spot mutations in ovarian gynandroblastoma.
    Wang Y; Karnezis AN; Magrill J; Tessier-Cloutier B; Lum A; Senz J; Gilks CB; McCluggage WG; Huntsman DG; Kommoss F
    Histopathology; 2018 Aug; 73(2):306-313. PubMed ID: 29660837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
    Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
    Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and genomics of ovarian sex cord-stromal tumors.
    Fuller PJ; Leung D; Chu S
    Clin Genet; 2017 Feb; 91(2):285-291. PubMed ID: 27813081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of molecular analysis in challenging ovarian sex cord-stromal tumours: a review of 50 cases.
    Stewart CJR; Amanuel B; De Kock L; Apellaniz-Ruiz M; Carrello A; Giardina T; Grieu-Iacopetta F; Thomas MA; Foulkes WD
    Pathology; 2020 Oct; 52(6):686-693. PubMed ID: 32782216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sex cord-stromal tumors of the ovary : Current aspects with a focus on granulosa cell tumors, Sertoli-Leydig cell tumors, and gynandroblastomas].
    Kommoss F; Lehr HA
    Pathologe; 2019 Feb; 40(1):61-72. PubMed ID: 30659330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
    Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
    [No Abstract]   [Full Text] [Related]  

  • 11. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
    Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
    Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
    Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
    Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
    Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
    Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
    Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
    Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
    Buza N; Wong S; Hui P
    Int J Gynecol Pathol; 2018 Jul; 37(4):305-315. PubMed ID: 28700438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
    Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
    Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
    Baillard P; Genestie C; Croce S; Descotes F; Rouleau E; Treilleux I; Gouy S; Morice P; Ray-Coquard I; McCluggage WG; Devouassoux-Shisheboran M
    Am J Surg Pathol; 2021 Feb; 45(2):223-229. PubMed ID: 32910017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
    McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
    Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries.
    Nelson AT; Harris AK; Watson D; Kamihara J; Chen KS; Stall JN; Devins KM; Young RH; Olson DR; Mallinger PHR; Mitchell SG; Hoffman LM; Halliday G; Suleymanova AM; Glade Bender JL; Messinger YH; Herzog CE; Field AL; Frazier AL; Stewart DR; Dehner LP; Hill DA; Billmire DF; Schneider DT; Schultz KAP
    Gynecol Oncol; 2024 Jul; 186():117-125. PubMed ID: 38657450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.